Nx Gen Sequencing Comprehensive Epilepsy Test sale cost 4680 AED
POLG Gene Alper's Syndrome Genetic Test sale cost 4400 AED POLG Gene Alper's Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Ganglioside GM-1 Antibodies IgG and IgM Test sale cost 3300 AED Ganglioside GM-1 Antibodies IgG and IgM Test Cost 4,800 د.إ Original price was: 4,800 د.إ.3,300 د.إCurrent price is: 3,300 د.إ.
Sale!

Nx Gen Sequencing Comprehensive Epilepsy Test Cost

Original price was: 5,200 د.إ.Current price is: 4,680 د.إ.

-10%

The Nx Gen Sequencing Comprehensive Epilepsy Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to provide in-depth insights into the genetic underpinnings of epilepsy. This test employs next-generation sequencing (NGS) technology to analyze multiple genes known to be associated with various forms of epilepsy, enabling precise identification of genetic variations that may contribute to the condition. With a cost of 4680 AED, the test aims to offer a comprehensive genetic assessment for individuals experiencing epilepsy, aiding in the customization of treatment plans and management strategies based on the patient’s unique genetic profile. By leveraging the power of NGS, DNA Labs UAE provides a valuable resource for patients and healthcare providers in the quest for more effective and personalized epilepsy care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test

Test Cost: AED 4680.0

Symptoms and Diagnosis

Epilepsy is a neurological disorder characterized by recurrent seizures. It can manifest in various ways, including convulsions, loss of consciousness, and abnormal movements or sensations. Diagnosing epilepsy involves a thorough evaluation of symptoms, medical history, and neurological examinations. In some cases, additional tests such as EEG (electroencephalogram) or brain imaging may be required to confirm the diagnosis.

Test Components

  • ACY1
  • ADRA2B
  • ADSL
  • ALDH7A1
  • AMT
  • ARHGEF15
  • ARHGEF9
  • ARX
  • ASAH1
  • CACNA1H
  • CACNB4
  • CDKL5
  • CERS1
  • CHRNA2
  • CHRNA4
  • CHRNB2
  • CLCN2
  • CNTNAP2
  • CPA6
  • CPT2
  • CSTB
  • DEPDC5
  • DRD2
  • EFHC1
  • EPM2A
  • FOLR1
  • FOXG1
  • GAB- RA1
  • GABRB3
  • GABRD
  • GABRG2
  • GAMT
  • GCSH
  • GLDC
  • GOSR2
  • GRIN2A
  • GRIN2B
  • JRK
  • KCNJ10
  • KCNMA1
  • KCNQ2
  • KCNQ3
  • KCNT1
  • KCTD7
  • LGI1
  • MAPK10
  • MBD5
  • MECP2
  • MEF2C
  • MFSD8
  • MTHFR
  • MTOR
  • NEDD4L
  • NEU1
  • NHLRC1
  • NOL3
  • NRXN1
  • PCDH19
  • PIGA
  • PIGO
  • PIGV
  • PLCB1
  • PNKP
  • PNPO
  • POLG
  • PPT1
  • PRICKLE1
  • PRICKLE2
  • PRRT2
  • QARS
  • RBFOX1
  • RBFOX3
  • RNASEH2A
  • RNASEH2B
  • RNASEH2C
  • ROGDI
  • SAMHD1
  • SCARB2
  • SCN1A
  • SCN1B
  • SCN2A
  • SCN3A
  • SCN8A
  • SCN9A
  • SGCE
  • SLC13A5
  • SLC19A3
  • SLC25A12
  • SLC25A22
  • SLC2A1
  • SLC35A2
  • SLC6A8
  • SLC9A6
  • SPTAN1
  • SRPX2
  • ST3GAL3
  • ST3GAL5
  • STXBP1
  • SYN1
  • SYNGAP1
  • SZT2
  • TBC1D24
  • TBCE
  • TCF4
  • TPP1
  • TREX1
  • TSC1
  • TSC2
  • UBE3A
  • WWOX
  • ZEB2

Price: AED 4680.0

Sample Condition

To perform the Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test, please submit 10 mL (minimum 5 mL) of whole blood from 2 Lavender Top (EDTA) tubes. The samples should be shipped refrigerated and should not be frozen. Additionally, a duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Report Delivery

The sample should be submitted daily by 9 am. The report will be delivered within 40 working days.

Method

The Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test utilizes Next-generation sequencing (NGS) and Sanger sequencing methods to analyze the genetic components. NGS allows for rapid and cost-effective sequencing of large amounts of DNA, while Sanger sequencing is a traditional method for DNA sequencing.

Test Type

The Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test falls under the category of Genetic Disorders-Epilepsy.

Doctor

This test is typically referred by a Neurologist.

Test Department

The test is conducted in the Molecular Diagnostics department.

Pre Test Information

A duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory before conducting the test.

Test Details

Next-generation sequencing (NGS) has revolutionized genomics by enabling rapid and cost-effective sequencing of large amounts of DNA. The Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test utilizes NGS technology to sequence the entire exome or even the entire genome of an individual with epilepsy. This comprehensive approach allows for the identification of genetic variants associated with epilepsy development or susceptibility.

By comparing the sequence data of an individual with epilepsy to a reference genome, researchers can identify genetic mutations, structural variations, or other genomic alterations that may contribute to epilepsy. These findings provide valuable insights into the genetic causes of epilepsy and can guide personalized treatment strategies.

In addition to whole exome or genome sequencing, targeted approaches can also be used to analyze specific epilepsy-related genes or gene panels. These targeted approaches increase the efficiency and sensitivity of the sequencing process.

The Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test offers a comprehensive analysis of the genetic basis of epilepsy and aids in the development of personalized treatment approaches for individuals with this condition.

Test Name Nx GEN SEQUENCING COMPREHENSIVE EPILEPSY Test
Components ACY1, ADRA2B, ADSL, ALDH7A1, AMT, ARHGEF15, ARHGEF9, ARX, ASAH1, CACNA1H, CACNB4, CDKL5, CERS1, CHRNA2, CHRNA4, CHRNB2, CLCN2, CNTNAP2, CPA6, CPT2, CSTB, DEPDC5, DRD2, EFHC1, EPM2A, FOLR1, FOXG1, GAB- RA1, GABRB3, GABRD, GABRG2, GAMT, GCSH, GLDC, GOSR2, GRIN2A, GRIN2B, JRK, KCNJ10, KCNMA1, KCNQ2, KCNQ3, KCNT1, KCTD7, LGI1, MAPK10, MBD5, MECP2, MEF2C, MFSD8, MTHFR, MTOR, NEDD4L, NEU1, NHLRC1, NOL3, NRXN1, PCDH19, PIGA, PIGO, PIGV, PLCB1, PNKP, PNPO, POLG, PPT1, PRICKLE1, PRICKLE2, PRRT2, QARS, RBFOX1, RBFOX3, RNASEH2A, RNASEH2B, RNASEH2C, ROGDI, SAMHD1, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SGCE, SLC13A5, SLC19A3, SLC25A12, SLC25A22, SLC2A1, SLC35A2, SLC6A8, SLC9A6, SPTAN1, SRPX2, ST3GAL3, ST3GAL5, STXBP1, SYN1, SYNGAP1, SZT2, TBC1D24, TBCE, TCF4, TPP1, TREX1, TSC1, TSC2, UBE3A, WWOX, ZEB2
Price 4680.0 AED
Sample Condition Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery Sample Daily by 9 am; Report 40 Working days
Method NGS, Sanger sequencing
Test type Genetic Disorders-Epilepsy
Doctor Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details

Next-generation sequencing (NGS) refers to the high-throughput DNA sequencing technologies that have revolutionized the field of genomics. NGS allows for the rapid and cost-effective sequencing of large amounts of DNA, enabling researchers to analyze entire genomes or specific regions of interest in a comprehensive manner.

A comprehensive epilepsy test using NGS would involve sequencing the entire exome (the protein-coding regions of the genome) or even the entire genome of an individual with epilepsy. This approach allows for the identification of genetic variants that may be associated with the development or susceptibility to epilepsy.

By comparing the sequence data of an individual with epilepsy to a reference genome, researchers can identify genetic mutations, structural variations, or other genomic alterations that may contribute to the development of epilepsy. These findings can help in understanding the underlying genetic causes of epilepsy and potentially guide personalized treatment strategies.

Comprehensive epilepsy tests using NGS can also involve the analysis of specific epilepsy-related genes or gene panels. These targeted approaches allow for a more focused analysis of genes known to be associated with epilepsy, increasing the sensitivity and efficiency of the sequencing process.

Overall, NGS-based comprehensive epilepsy tests have the potential to provide valuable insights into the genetic basis of epilepsy and aid in the development of personalized treatment approaches for individuals with this condition.

SKU: TEST-4624 Category:

Related products